OpenClinica, a provider of a cloud-based eClinical platform that simplifies conducting clinical trials for biopharmaceutical companies, contract research organizations, academic institutions, and government agencies, received an investment from Thompson Street Capital Partners.
Terms of the funding deal were not disclosed.
With new funds, OpenClinica plans to advance its cloud technology platform that simplifies running clinical trials for 10,000+ clinical studies worldwide. The platform enables biopharmaceutical companies, contract research organizations, academic institutions, and government agencies to speed up clinical research by automatically capturing data from electronic health records and integrating it with existing clinical workflows.
Commenting on the funding news, Cal Collins, Co-Founder and CEO of OpenClinica, said: “Thompson Street Capital Partners and OpenClinica are united around a shared vision for overcoming the challenges of data collection and enabling more efficient clinical research through data management and automation.” “It was critical that we found a partner aligned with our goals and values, and we are thrilled to partner with TSCP to expand our offerings and reach.”
Commenting on the funding news, Matt Scherrer, Managing Director at Thompson Street Capital Partners (TSCP), said: “OpenClinica provides the tools, automation, and resources to facilitate significant opportunities for clinical researchers and make it easier to bring the next iteration of therapeutic and biotechnology discoveries to market.”
“TSCP is proud to back Cal, Ben, and their management team to advance their growth and leadership position in eClinical technology, and we look forward to working with them to drive the company’s next phase of growth,” added Matt Scherrer.
Digital clinical trial startups have raised almost $2 billion in funding to date, according to our funding database.
Faro Health, a provider of an end-to-end clinical trial management platform for biopharma and medical device companies, raised $20 million in additional funding.
SubjectWell, an online clinical trials marketplace for people suffering from chronic health conditions, raised $35 million in Series B funding led by Asset Management Ventures, with participation from all existing investors, Healthy Ventures, Windham Venture Partners, and Geekdom Fund.
HealthMatch, an online clinical trial recruitment platform that helps users find and schedule the right clinical trials in Australia, raised A$10 million in Series C funding led by Folklore Ventures with Square Peg Capital.